SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Cacaito who wrote (2263)11/8/1997 10:41:00 PM
From: Ibexx  Read Replies (2) | Respond to of 23519
 
Calcaito,

Phase IV (post-market) studies monitor untoward side-effects closely for any approved drug, and DEATH is not a trivial event whether it occurs in a 79-year old or a teenager.

It wouldn't need more than a few occurances of this kind to get the drug off the shelf.

Ibexx
(Who spent 2/3 of professioanl life
doing ethical drug development)